These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15320941)

  • 21. Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase.
    Gu J; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(2):69-77. PubMed ID: 19229698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gas bioengineering using hemoglobin-vesicles for versatile clinical applications.
    Sakai H; Takeoka S; Kobayashi K
    Curr Pharm Des; 2011; 17(22):2352-9. PubMed ID: 21736544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridoxalated hemoglobin polyoxyethylene: a nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock.
    Privalle C; Talarico T; Keng T; DeAngelo J
    Free Radic Biol Med; 2000 May; 28(10):1507-17. PubMed ID: 10927175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic effects of the red blood cell substitutes cross-linked and non-cross-linked hemoglobins on hematopoiesis in rabbits.
    Lutton JD; Jiang S; Drummond GS; Abraham NG; Levere RD; Kappas A
    Pharmacology; 1999 Jun; 58(6):319-24. PubMed ID: 10325577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-linked stroma-free polyhemoglobin as a potential blood substitute.
    Keipert P; Minkowitz J; Chang TM
    Int J Artif Organs; 1982 Nov; 5(6):383-5. PubMed ID: 7160935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymerized hemoglobin induces heme oxygenase-1 protein expression and inhibits intercellular adhesion molecule-1 protein expression in human lung microvascular endothelial cells.
    Cheng AM; Moore EE; Johnson JL; Walsh MD; Ao L; Moore PK; Banerjee A
    J Am Coll Surg; 2005 Oct; 201(4):579-84. PubMed ID: 16183497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemoglobin substitutes.
    Anbari KK; Garino JP; Mackenzie CF
    Eur Spine J; 2004 Oct; 13 Suppl 1(Suppl 1):S76-82. PubMed ID: 15168238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PolyHeme. Northfield Laboratories.
    Jahr JS; Varma N
    IDrugs; 2004 May; 7(5):478-82. PubMed ID: 15154110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation.
    Chang TM; D'Agnillo F; Yu WP; Razack S
    Adv Drug Deliv Rev; 2000 Feb; 40(3):213-8. PubMed ID: 10837791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artificial oxygen carriers: a current review.
    Henkel-Honke T; Oleck M
    AANA J; 2007 Jun; 75(3):205-11. PubMed ID: 17591302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial blood.
    Squires JE
    Science; 2002 Feb; 295(5557):1002-5. PubMed ID: 11834811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red blood cell substitutes: microencapsulated hemoglobin and cross-linked hemoglobin including pyridoxylated polyhemoglobin & conjugated hemoglobin.
    Chang TM
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):11-29. PubMed ID: 3052638
    [No Abstract]   [Full Text] [Related]  

  • 33. Red blood cell substitutes.
    Chang TM
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):651-67. PubMed ID: 11102282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of modified polyhemoglobin on the ischemia/reperfusion injury in kidney.
    Mun KC; Lee HG; Lee TH; Kim YH; Kwak CS; Kim SP; Chang EJ; Park SB; Kim HC
    Transplant Proc; 2003 Feb; 35(1):99-100. PubMed ID: 12591324
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemoglobin-albumin crosslinked copolymers: reduced prooxidant reactivity.
    Iacob B; Deac F; Cioloboc D; Damian G; Silaghi-Dumitrescu R
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Oct; 39(5):293-7. PubMed ID: 21623694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemoglobin-based oxygen carriers for hemorrhagic shock.
    Elmer J; Alam HB; Wilcox SR
    Resuscitation; 2012 Mar; 83(3):285-92. PubMed ID: 21978876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial oxygen carrier with pharmacologic actions of adenosine-5'-triphosphate, adenosine, and reduced glutathione formulated to treat an array of medical conditions.
    Simoni J; Simoni G; Moeller JF; Feola M; Wesson DE
    Artif Organs; 2014 Aug; 38(8):684-90. PubMed ID: 24980041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-linked hemoglobins being well into clinical trials, increasing research efforts are now on a second generation red blood cell substitute based on encapsulated hemoglobin.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):257-62. PubMed ID: 7493046
    [No Abstract]   [Full Text] [Related]  

  • 39. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes.
    Olson JS; Foley EW; Rogge C; Tsai AL; Doyle MP; Lemon DD
    Free Radic Biol Med; 2004 Mar; 36(6):685-97. PubMed ID: 14990349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resuscitation with recombinant hemoglobin rHb2.0 in a rodent model of hemorrhagic shock.
    Hermann J; Corso C; Messmer KF
    Anesthesiology; 2007 Aug; 107(2):273-80. PubMed ID: 17667572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.